HZB-0071

N/A

Report date: 2023/03/20 14:51:24
NME

Base Information

Drug NameHZB-0071
Drug Alias NameHZB-0071
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase AKT1 inhibitorsSerine/threonine-protein kinase AKT2 inhibitorsSerine/threonine-protein kinase AKT3 inhibitors
TargetsSerine/threonine-protein kinase AKT1Serine/threonine-protein kinase AKT3Serine/threonine-protein kinase AKT2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWuxi Apptec Co LtdHeilongjiang Zbd Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHarbin Zhenbao Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A